The BRCA1 BRCT Promotes Antisense RNA Production and Double-stranded RNA Formation to Suppress Ribosomal R-loops
Overview
Affiliations
R-loops, or RNA:DNA hybrids, can induce DNA damage, which requires DNA repair factors including breast cancer type 1 susceptibility protein (BRCA1) to restore genomic integrity. To date, several pathogenic mutations have been found within the tandem BRCA1 carboxyl-terminal (BRCT) domains that mediate BRCA1 interactions with proteins and DNA in response to DNA damage. Here, we describe a nonrepair role of BRCA1 BRCT in suppressing ribosomal R-loops via two mechanisms. Through its RNA binding and annealing activities, BRCA1 BRCT facilitates the formation of double-stranded RNA between ribosomal RNA (rRNA) and antisense-rRNA (as-rRNA), hereby minimizing rRNA hybridization to ribosomal DNA to form R-loops. BRCA1 BRCT also promotes RNA polymerase I-dependent transcription of as-rRNA to enhance double-stranded rRNA (ds-rRNA) formation. In addition, BRCA1 BRCT-mediated as-rRNA production restricts rRNA maturation in unperturbed cells. Hence, impairing as-rRNA transcription and ds-rRNA formation due to BRCA1 BRCT deficiency deregulates rRNA processing and increases ribosomal R-loops and DNA breaks. Our results link ribosomal biogenesis dysfunction to BRCA1-associated genomic instability.
Conserved GTPase OLA1 promotes efficient translation on D/E-rich mRNA.
Yu T, Li X, Dong W, Zhou Q, Li Q, Du Z Nat Commun. 2025; 16(1):1549.
PMID: 39934121 PMC: 11814078. DOI: 10.1038/s41467-025-56797-8.
DDX41: exploring the roles of a versatile helicase.
Winstone L, Jung Y, Wu Y Biochem Soc Trans. 2024; 52(1):395-405.
PMID: 38348889 PMC: 10903454. DOI: 10.1042/BST20230725.
Zheng L, Shi S, Sun X, Lu M, Liao Y, Zhu S Brief Bioinform. 2024; 25(2).
PMID: 38305456 PMC: 10835750. DOI: 10.1093/bib/bbae006.
Targeting the / deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights.
Ragupathi A, Singh M, Perez A, Zhang D Front Cell Dev Biol. 2023; 11:1133472.
PMID: 37035242 PMC: 10073599. DOI: 10.3389/fcell.2023.1133472.